STAT3 and familial pancreatic carcinoma: This finding is especially exciting in regard to the recently published results of Scholz et al (2003), demonstrating that activated Stat3 can promote the malignant phenotype of human pancreatic cancer by acceleration of G1/S-phase progression and thus supporting our present results.